Othram, The Woodlands, TX-based developer of technology for investigators to crack unsolved law enforcement cases through advanced genomics, raised $18m in Series B funding.
The round was led by Gigafund. In conjunction with the funding, Stephen Oskoui, Managing Partner of Gigafund, will join Othram’s board.
The company intends to use the funds to further develop its genetic testing platform and expand operations throughout North America.
Led by David Mittelman, CEO, Othram is a DNA laboratory built specifically to apply modern parallel sequencing to forensic evidence. The facility combines genome sequencing with advanced human identification applications to offer end-to-end, in-house processing from forensic evidence to investigative leads. The team works with academic researchers, forensic scientists, medical examiners, and law enforcement agencies and, over the last three years, they have helped law enforcement crack cases at the local, state, and federal level, many of which had been unsolved for decades.